advertisement
Spry PG 15
Showing records 1 to 15 | Display all abstracts from Spry PG60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath DF
Lancet 2015; 385: 1295-1304
60646 Nigeria normative data for defining glaucoma in prevalence surveys
Kyari F; Abdull MM
Ophthalmic Epidemiology 2015; 22: 98-108
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Crabb DP; Bunce C
Lancet 2015; 385: 1295-1304
60646 Nigeria normative data for defining glaucoma in prevalence surveys
Sallo FB; Spry PG
Ophthalmic Epidemiology 2015; 22: 98-108
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Lascaratos G
Lancet 2015; 385: 1295-1304
60646 Nigeria normative data for defining glaucoma in prevalence surveys
Wormald R
Ophthalmic Epidemiology 2015; 22: 98-108
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Amalfitano F
Lancet 2015; 385: 1295-1304
60646 Nigeria normative data for defining glaucoma in prevalence surveys
Peto T
Ophthalmic Epidemiology 2015; 22: 98-108
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Anand N
Lancet 2015; 385: 1295-1304
60646 Nigeria normative data for defining glaucoma in prevalence surveys
Faal HB
Ophthalmic Epidemiology 2015; 22: 98-108
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Azuara-Blanco A; Bourne RR
Lancet 2015; 385: 1295-1304
60646 Nigeria normative data for defining glaucoma in prevalence surveys
Gilbert CE
Ophthalmic Epidemiology 2015; 22: 98-108
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Broadway DC
Lancet 2015; 385: 1295-1304
60646 Nigeria normative data for defining glaucoma in prevalence surveys
Ophthalmic Epidemiology 2015; 22: 98-108
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Cunliffe IA; Diamond JP; Fraser SG; Ho TA; Martin KR; McNaught AI; Negi A; Patel K; Russell RA; Shah A; Spry PG; Suzuki K; White ET; Wormald
Lancet 2015; 385: 1295-1304
